The Indian government’s think tank NITI Aayog, on Thursday, in a myth-busting exercise, claimed that the Centre had proactively eased the entry of foreign vaccines into the country. However, in February, the expert panel under India’s drug regulator had declined to recommend emergency use authorisation for Pfizer’s mRNA vaccine. Pfizer subsequently withdrew its application. As Covid cases swelled in India, on April 13, the government waived the condition of phase 2 and 3 clinical trials in the country for vaccines cleared by the US, EU, UK and Japanese regulators and listed by the World Health Organisation (WHO).
On Friday, Javadekar countered the Congress’s criticism of the Centre’s Covid vaccination efforts by referring to the ‘Congress’ toolkit, an online document several leaders of the ruling Bharatiya Janata Party (BJP) claim was devised by the Congress to malign Prime Minister Narendra Modi.